Skip to main content
Onconic Therapeutics Inc. logo

Onconic Therapeutics Inc. — Investor Relations & Filings

Ticker · 476060 ISIN · KR7476060009 KO Manufacturing
Open in API
Filings indexed 125 across all filing types
Latest filing 2026-05-11 Regulatory Filings
Country KR South Korea
Listing KO 476060

About Onconic Therapeutics Inc.

http://onconic.co.kr/

Onconic Therapeutics Inc., established in 2020, is a biopharmaceutical company specializing in the research and development of innovative drugs. A subsidiary of Jeil Pharmaceutical, the company focuses on creating novel treatments for cancer and gastrointestinal disorders, including gastroesophageal reflux disease. Its development strategy prioritizes therapeutics for conditions with high unmet medical needs and significant market potential. Onconic Therapeutics actively advances its pipeline of drug candidates through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(임상시험계획변경승인신청) (자큐보구강붕해정(JLP2302)(자스타프라잔시트르산염)의 비위관투여 시 약동학 및 안전성 비교평가를 위한 제1상 임상시험계획승인(변경승인)신청)
Regulatory Filings Classification · 94% confidence The document is a Korean stock exchange material event disclosure (“투자판단 관련 주요경영사항”) detailing a clinical trial plan change application. It contains no financial statements, earnings data, or board/management changes, and simply announces a regulatory submission. This fits the catch-all Regulatory Filings category.
2026-05-11 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” covering the period 2026-01-01 to 2026-03-31 (7th fiscal period) and contains detailed company overview, business description, capital changes, share data, governance updates, and pipeline information consistent with a full quarterly financial report rather than a mere announcement. It clearly represents an Interim/Quarterly Report under the definition. Q1 2026
2026-05-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about share ownership changes by an executive named 차현주, including dates, share quantities, and transaction details. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange. The content focuses on insider shareholding disclosures rather than financial results, management changes, or other report types. The document length is 2530 characters, which is relatively short and specific to insider share transactions. Therefore, this fits the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades).
2026-05-06 Korean
기업설명회(IR)개최
Investor Presentation Classification · 85% confidence The document is an announcement of an upcoming investor relations event (‘기업설명회(IR) 개최’), providing date, location, participants, purpose, and posting details of IR materials. It is not a financial report itself but an investor presentation event notice, matching the Investor Presentation category.
2026-04-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a Korean regulatory filing titled "임원ㆍ주요주주 특정증권등 소유상황보고서" which details changes in ownership of securities by a company executive (executive shareholdings, acquisition/disposition dates and quantities). This matches the definition of a Director's Dealing report (insider transactions by directors/executives). It is not an annual or interim report, nor an earnings release or proxy statement, but a personal share transaction filing. Therefore, it should be classified as DIRS.
2026-04-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean regulatory report titled "임원ㆍ주요주주 특정증권등 소유상황보고서" (Report on ownership of specific securities by officers and major shareholders). It details the holdings and transactions (stock purchase claim exercises) by an executive (director) in the issuer, including share counts before and after, dates, and transaction reasons. This matches the insider trading/personal share transaction filings by directors. Therefore, it is classified as Director's Dealing (DIRS).
2026-04-17 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.